FDA seeks tough warning on Genentech asthma drug
Wed, 21 Feb 2007 05:32 PM EST
... WASHINGTON (Reuters) - Genentech Inc's asthma drug Xolair should carry the strongest warning possible about the drug's risk of a serious reaction known as anaphylaxis, U.S. health regulators said on Wednesday. ...
Related Topics
- Asthma & Allergies
- Asthma
- Asthma in Children
- Tacrolimus ointment
- Drug Safety
- Pimecrolimus Cream 1%
- Rofecoxib
- Prescription Drugs
- Montelukast
- Treatment
- Drug Side Effects
- Pregnancy and Substance Abuse
- Bevacizumab Injection
- Treatments
- Drug Abuse
- Drug Information
- Prescription Drug Abuse
- Prescription Drugs Abuse
- Tysabri
- Amphetamine and Dextroamphetamine ER

Not Signed In -


